Poland, Gregory A. http://orcid.org/0000-0001-5057-4457
Kennedy, Richard B. http://orcid.org/0000-0001-6164-4967
Article History
First Online: 23 February 2022
Competing interests
: G.A.P. offers consultative advice on vaccine and antiviral development to AstraZeneca, Pfizer, Medicago, Emergent Biosolutions, Johnson&Johnson/Janssen, Novavax, Moderna, Merck Research Laboratories, Glaxo SmithKline, Sanofi Pasteur, Eli Lilly and Company, Exelixis, Genevant, Regeneron Pharmaceuticals, Syneos Health and Vyriad. G.A.P. has received grant funding and royalties from ICW Healthcare Ventures for preclinical studies on a peptide-based COVID-19 vaccine for which he is an inventor. These activities are conducted in compliance with Mayo Clinic Conflict of Interest policies. R.B.K. has received royalties from ICW Healthcare Ventures for licensing of peptide vaccine development patents and intellectual property owned by Mayo Clinic of which he is an inventor or co-inventor. R.B.K. has consulted with Merck Research Laboratories on measles vaccines and with Sanofi Pasteur and Outcomes Insights on influenza vaccines.
Free to read: This content has been made available to all.